Paid-in Capital Increase Decision Amended
아이큐어
175250
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2819
Risk-adjusted indicator based on 2819 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Event: Paid-in Capital Increase
- • Status: Amendment to previous decision
AI Analysis Summary
Icure Pharmaceutical has filed an amendment to a previous decision regarding a paid-in capital increase. While specific figures are not available, a capital increase typically leads to share dilution, which can negatively impact existing shareholder value. The purpose of the funds and the terms of the issuance would be critical for a more detailed assessment.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.